Bliss GVS Pharma informs about board meeting

12 Nov 2019 Evaluate

Bliss GVS Pharma has informed that Board Meeting of the Company was held on Monday, November 11, 2019 at the registered office of the Company. The Board has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2019. A copy of unaudited financial results along with the Limited Review Report of the Auditor of the Company are enclosed herewith as Annexure-I. The meeting of the Board of Directors commenced at 6.30 pm and concluded at 9.15 pm.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

131.50 2.50 (1.94%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.